• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

The future of AGN? Are you happy PFE is gone?

anonymous

Guest
The feelings on the Irvine campus are generally bad. People are not happy with the way things are now that actavis has taken over and in particular the leadership in JC/Irvine. Many were hoping that PFE would put an end to a lot of it, but now feel hopeless. The meetings, townhalls, etc. that we have all say positive things, but the actions of our leaders are the complete opposite. Actions speak louder than words. Are you hopeful?
 




PFE was the light at the end of the tunnel, and now that light has gone.

Now we're stuck in the new Valeant, with small-time guys running a very big ship.

Unlikely to be acquired, but very likely to acquire more poor souls.
 




PFE was the light at the end of the tunnel, and now that light has gone.

Now we're stuck in the new Valeant, with small-time guys running a very big ship.

Unlikely to be acquired, but very likely to acquire more poor souls.

I feel for you guys. Pfizer isn't perfect, but they do still respect their employees and treat them well. Who knows? Maybe Brent Saunders will have his Peter's Principle moment. He does seem to be way over his head, and doesn't really know how to run a company. The fact that he even pretended to be the future CEO of Pfizer was laughable. I wish you the best.